Hyperemesis gravidarum and vitamin K deficiency: a systematic review.
Kelly NijstenLoïs van der MinnenHanke M G WiegersMarjette H KootSaskia MiddeldorpTessa J RoseboomIris J GrootenRebecca C PainterPublished in: The British journal of nutrition (2021)
Hyperemesis gravidarum (HG), severe nausea and vomiting in pregnancy, can lead to vitamin deficiencies. Little is known about HG-related vitamin K deficiency. We aimed to summarise available evidence on the occurrence of HG-related vitamin K deficiency and corresponding maternal and neonatal complications. A systematic review was conducted, searching Medline and EMBASE from inception to 12 November 2020. We identified 1564 articles, of which we included fifteen in this study: fourteen case reports (n 21 women) and one retrospective cohort study (n 109 women). Nine out of twenty-one women reported in case reports had a prolonged prothrombin time (PT). The cohort study measured PT in 39/109 women with HG, of whom 10/39 women (26 %) had prolonged PT. In total, 30-50 % women received vitamin K supplementation after vitamin K deficiency had been diagnosed. Four case reports (n 4 women) reported corresponding maternal complications, all consisting of coagulopathy-related haemorrhage. Nine case reports (n 16 neonates) reported corresponding neonatal complications including intracranial haemorrhage (n 2 neonates) and embryopathy (n 14 neonates), which consisted of Binder phenotype (n 14 neonates), chondrodysplasia punctata (n 9 neonates) and grey matter heterotopia (n 3 neonates). In conclusion, vitamin K deficiency and related complications occur among women with HG. In our systematic review, we were unable to assess the incidence rate.
Keyphrases
- pregnancy outcomes
- polycystic ovary syndrome
- systematic review
- low birth weight
- risk factors
- case report
- cervical cancer screening
- pregnant women
- fluorescent probe
- breast cancer risk
- randomized controlled trial
- preterm infants
- risk assessment
- replacement therapy
- metabolic syndrome
- insulin resistance
- multiple sclerosis
- early onset
- drug induced
- body mass index
- smoking cessation